Nursing care
Supraventricular Tachycardia nursing care: what to assess and what to do first
Written and reviewed by Dana Whitfield, RN, MSN · 6 min read · Updated September 2026
Short answer
Supraventricular tachycardia is managed with vagal manoeuvres first, then IV adenosine if those fail. Warn the patient before adenosine: they will feel a few seconds of chest pressure, flushing, or a sense of impending doom as the drug briefly stops the heart's conduction through the AV node. Continuous ECG and a rapid push through a large-bore line are essential.
The pathophysiology in one pass
SVT arises above the ventricles, usually from a re-entrant circuit involving the AV node or an accessory pathway. The most common form, AV nodal re-entrant tachycardia, sets up a loop where an impulse travels down one AV nodal pathway and back up another, retriggering itself faster than the sinus node can compete. The result is a narrow-complex tachycardia, typically 150 to 250 beats per minute, that starts and stops abruptly rather than ramping up gradually like sinus tachycardia.
Because the rhythm originates above the ventricles, the QRS complex stays narrow unless there is an underlying bundle branch block or aberrant conduction. P waves are often buried in the preceding T wave or absent altogether, which is why the ECG can look deceptively clean apart from the rate. The abruptness of onset and offset is the clinical fingerprint that separates SVT from other tachyarrhythmias, and it is exactly what makes vagal manoeuvres and adenosine effective: both interrupt the AV node, breaking the re-entrant loop rather than treating an underlying automaticity problem.
Assessment findings that matter
Ask about onset. Patients with SVT often describe a sudden pounding or racing sensation that started and stopped like a switch being flipped, sometimes triggered by caffeine, stress, or a change in position. This history alone distinguishes SVT from sinus tachycardia, which climbs and falls gradually with exertion or fever.
Check haemodynamic stability before anything else. Blood pressure, level of consciousness, skin colour and capillary refill tell you whether this patient tolerates the rate or is decompensating. A rate above 150 in a patient with chest pain, hypotension, or altered mentation is unstable and changes the whole plan. Palpate pulses for regularity, auscultate for a rate too fast to count accurately by hand, and get a 12-lead ECG as soon as it is safe to do so, since it confirms the narrow QRS and helps rule out atrial fibrillation or flutter, which are managed differently.
What the exam asks about this
NCLEX-style questions on SVT usually test sequencing: what do you do first, second, and third. The expected order is vagal manoeuvres, then adenosine, then synchronised cardioversion if the patient is unstable or adenosine fails. Questions often present a stable patient and ask you to select the initial nursing action, and the correct answer is a vagal manoeuvre such as bearing down or coughing, not immediately paging for medication.
A second common pattern is a patient teaching or safety question about adenosine itself: what to tell the patient before giving it, and what to expect on the monitor afterward. Expect distractors that suggest calling for cardioversion first or giving a beta-blocker before trying vagal manoeuvres. The exam rewards priority-setting that matches the actual algorithm, not just knowing the drug name.
Nursing interventions in priority order
Start with vagal manoeuvres if the patient is stable. Valsalva, done properly by having the patient bear down against a closed glottis for 10 to 15 seconds, is more effective than the older instruction to simply 'bear down,' and modified techniques such as bearing down while supine with legs raised afterward improve success rates further. Carotid sinus massage is an option in younger patients without carotid disease but is used less often given the stroke risk in older adults.
If vagal manoeuvres fail, prepare for IV adenosine. Establish or confirm a large-bore IV, ideally in the antecubital fossa, since the drug's half-life is under 10 seconds and a sluggish line blunts its effect. Have continuous ECG running and a printout capturing the moment of administration, because the brief AV block adenosine produces is often the only clear look at the underlying atrial rhythm. If the patient is unstable, synchronised cardioversion takes priority over any drug.
Medications and monitoring
Adenosine is given as a rapid IV push, typically 6 mg followed immediately by a fast saline flush, with a second dose of 12 mg if the first does not convert the rhythm. Speed matters more with this drug than almost any other on the unit: a slow push through a small vein will fail to reach the heart before it is metabolised. Warn the patient beforehand that they will likely feel chest pressure, flushing, or a brief sense of impending doom, and that the heart may feel like it stops for a few seconds. It does, briefly, and that sensation is expected, not a sign something has gone wrong.
Watch the monitor continuously through the push. A short period of asystole or bradycardia is expected and usually resolves within seconds as the AV block wears off. If SVT recurs frequently, the patient may be started on a beta-blocker or calcium channel blocker for longer-term rate control, and diltiazem or verapamil are reasonable alternatives to adenosine in patients who do not respond or who have contraindications such as severe asthma.
When to escalate
Escalate immediately if the patient becomes hypotensive, loses consciousness, develops chest pain suggestive of ischaemia, or shows signs of pulmonary oedema. These are markers of instability that shift management from pharmacological conversion to synchronised cardioversion, and delay increases risk.
Also escalate if adenosine fails to convert the rhythm after two appropriately dosed attempts, if the rhythm converts and then rapidly recurs, or if the ECG suggests Wolff-Parkinson-White syndrome, since AV nodal blocking agents can be dangerous in the presence of an accessory pathway conducting to the ventricles. Any uncertainty about the rhythm strip, especially a wide-complex tachycardia that might be ventricular rather than supraventricular, warrants immediate physician or rapid response involvement rather than a trial of adenosine.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our cardiovascular practice questions are the closest set to what this page covers.
Common questions
Why does adenosine have to be pushed so fast?
Adenosine has a half-life of less than 10 seconds because it is rapidly taken up by red blood cells and endothelium. A slow push means the drug is largely metabolised before it reaches the AV node, so it is given as a rapid bolus through a large-bore IV, immediately followed by a fast saline flush to carry it to the heart.
Is it normal for the patient to feel like they are dying after adenosine?
Yes. The brief AV block adenosine causes stops conduction for a few seconds, and patients commonly describe chest pressure, flushing, or a sense of impending doom during that window. It resolves within seconds as the block wears off, and warning the patient beforehand reduces the fear when it happens.
What is the difference between SVT and sinus tachycardia on assessment?
Sinus tachycardia climbs and falls gradually and usually has an identifiable cause such as fever, pain, or exertion, with normal P waves preceding each QRS. SVT starts and stops abruptly, often has no visible P wave, and is not explained by a proportional physiological trigger.
Can vagal manoeuvres be tried more than once?
Yes, a repeat attempt with correct technique, such as Valsalva combined with leg raise immediately afterward, is reasonable before moving to adenosine, provided the patient remains stable. If the patient is unstable, do not delay escalation for repeated attempts.
Why is adenosine avoided in some patients with SVT?
Adenosine can cause bronchospasm and is used cautiously in patients with severe asthma or COPD, where calcium channel blockers such as diltiazem may be preferred. It is also avoided when Wolff-Parkinson-White with a wide-complex or irregular rhythm is suspected, since blocking the AV node can promote conduction down an accessory pathway.
More on cardiovascular
Guides on this